Arrivent is a company that specializes in providing innovative solutions in the technology sector. The company focuses on leveraging cutting-edge technology to deliver products and services that enhance efficiency and drive digital transformation for its clients.

ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.

Boyu Capital

Lilly Asia Ventures

Lyra Capital

Octagon Capital Advisors

OrbiMed

Hillhouse Capital Group

Sirona Capital

AIHC Capital

Sequoia Capital China

Shanghai Healthcare Capital

Catalio Capital Management

HBM Healthcare Investments AG

HBM Partners

Infinitum Partners

ArriVent Biopharma

Arrivent

COM:ARRIVENT

Arrivent

Analysis Not Available